Diabetes therapy must shift beyond glucose control to holistic biological systems redesign.
Diabetes Therapeutics Beyond Hyperglycaemia: Toward Biological Systems Redesign
Abstract
Current diabetes pharmacology, focused on glucose lowering, fails to curb complications. A paradigm shift toward biological systems redesign is essential for better outcomes.